1. Acute urticaria alone after CoronaVac COVID‐19 vaccination should not be a contraindication for revaccination.
- Author
-
Triwatcharikorn, J., Puaratana‐arunkon, T., Punyaratabandhu, P., Mongkolpathumrat, P., Palapinyo, S., Buranapraditkul, S., Rerknimitr, P., and Klaewsongkram, J.
- Subjects
BOOSTER vaccines ,COVID-19 vaccines ,URTICARIA ,VIRAL vaccines ,CONTRAINDICATIONS - Abstract
Summary: Patients who develop an immediate allergic reaction within the first 4 h of COVID‐19 vaccine injection are recommended not to receive the same vaccine again. This recommendation mainly focuses on the mRNA and adenoviral vector COVID‐19 vaccines, but data for whole virus vaccines are unknown. We report seven patients who developed an immediate reaction within 4 h (six had generalized urticaria, one had localized urticaria) after the first vaccination with CoronaVac, the inactivated SARS‐CoV‐2 vaccine. The results of skin tests and basophil activation tests suggested that spike peptides play a role in exacerbating urticaria in some patients. However, all subjects who developed urticaria within 4 h after CoronaVac vaccination were successfully revaccinated without graded challenge, although recurrent urticaria was common. This preliminary result indicates that acute urticaria alone should not be a contraindication for the second dose of CoronaVac if the supply of alternative vaccines is limited. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF